Essex Investment Management CO LLC Paratek Pharmaceuticals, Inc. Transaction History

Essex Investment Management CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$4.7 - $7.24 $840,595 - $1.29 Million	-178,850 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$6.81 - $10.93 $105,194 - $168,835	-15,447 Reduced 7.95%	178,850 $1.22 Million
Q1 2021 May 12, 2021	SELL	$6.14 - $8.31 $125,771 - $170,222	-20,484 Reduced 9.54%	194,297 $1.37 Million
Q4 2020 Feb 12, 2021	SELL	$4.58 - $7.14 $183,749 - $286,456	-40,120 Reduced 15.74%	214,781 $1.35 Million
Q3 2020 Nov 12, 2020	BUY	$4.19 - $6.69 $35,267 - $56,309	8,417 Added 3.41%	254,901 $1.38 Million
Q2 2020 Aug 04, 2020	BUY	$2.97 - $5.22 $732,057 - $1.29 Million	246,484 New	246,484 $1.29 Million
Q1 2018 Apr 26, 2018	SELL	$12.65 - $18.85 $382,991 - $570,702	-30,276 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$17.45 - $25.6 $564,647 - $828,364	-32,358 Reduced 51.66%	30,276 $542,000
Q3 2017 Oct 30, 2017	BUY	$18.9 - $28.2 $1.18 Million - $1.77 Million	62,634	62,634 $1.57 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.